Bipolar disorder is a lifelong condition, but it’s one that millions of people manage successfully — and medication is usually a central part of how they do it.
If you or someone you care about has been diagnosed with bipolar disorder, the medications your doctor mentions can feel overwhelming quickly. Terms like “mood stabilizer,” “atypical antipsychotic,” and “anticonvulsant” come up repeatedly, often with little explanation of what distinguishes them or why one might be chosen over another.
This guide breaks down the main classes of top bipolar medications in plain terms: what each type does, which phase of the condition it targets, and what factors shape how doctors approach treatment. It isn’t a substitute for working with a psychiatrist — medication decisions for bipolar disorder are highly individualized — but it can help you ask better questions and understand what you’re hearing.
What Types of Medications Are Used to Treat Bipolar Disorder?
Bipolar disorder involves two distinct types of episodes — manic highs and depressive lows — and no single medication addresses both equally well. That’s why treatment usually involves more than one medication, and why they come from several different classes.
The main categories include mood stabilizers, which form the foundation of most bipolar treatment plans; anticonvulsants, a subset of mood stabilizers originally developed for epilepsy but widely used in bipolar care; atypical antipsychotics, used for mania, mixed episodes, and increasingly for bipolar depression; and combination agents, FDA-approved medications that pair two drugs in a single formulation specifically for bipolar depression.
Most people with bipolar disorder take more than one of these medications at the same time. A mood stabilizer might handle the long-term baseline while an antipsychotic addresses acute episodes.Understanding medications for depression or anxiety follows similar principles — but bipolar disorder requires a distinct approach because of the manic component.
Mood Stabilizers — The Cornerstone of Bipolar Treatment
The term “mood stabilizer” covers medications that reduce the frequency and severity of mood episodes without pushing a person too far in either direction. Three drugs are most central to this category in bipolar care.
Lithium
Lithium is the oldest and most extensively studied medication for bipolar disorder, with two FDA-approved uses: managing acute manic or mixed episodes, and long-term maintenance to reduce how often episodes occur.
Researchers don’t fully understand why lithium works, but it’s thought to influence multiple chemical signaling pathways in the brain. According to the National Institute of Mental Health, lithium is particularly effective for people with classic bipolar I presentation, a family history of bipolar disorder, and episodes that are clearly separated by stable periods in between.
Lithium requires regular blood monitoring to ensure levels stay within a therapeutic range. The window between an effective dose and a problematic one is relatively narrow, making ongoing medical supervision essential — not optional.
Valproate (Depakote)
Valproate — sold under brand names including Depakote and Depakene — is an anticonvulsant originally developed to treat seizures. It’s FDA-approved for acute mania in bipolar disorder and is widely used in clinical practice.
It tends to be favored in situations where lithium isn’t the right fit: mixed episodes where mania and depression overlap, rapid cycling (four or more mood episodes per year), and manic presentations that include irritability or agitation rather than elevated mood. Like lithium, valproate requires blood monitoring, and prescribers weigh specific risks depending on a person’s health profile and circumstances.
Lamotrigine (Lamictal)
Lamotrigine — brand name Lamictal — is another anticonvulsant adapted for bipolar disorder. Its FDA indication is narrower: it’s approved for maintenance treatment of bipolar I, not for treating acute mania.
What sets lamotrigine apart from others in this class is where it works best — bipolar depression. Among mood stabilizers, it has the strongest evidence for preventing depressive episodes, which are often undertreated relative to mania. According to MedlinePlus, it’s used as long-term maintenance treatment to extend the time between episodes of depression, mania, and hypomania.
Lamotrigine is generally well-tolerated, with a lower risk of weight gain than some other options. The tradeoff is a slow titration schedule — doses are increased gradually over several weeks to reduce the risk of a serious skin reaction — so reaching a therapeutic dose takes time.
Atypical Antipsychotics for Bipolar Disorder
Atypical antipsychotics are a broad class of medications used in bipolar disorder, often alongside a mood stabilizer but sometimes on their own. Despite the name, these medications are used in bipolar care even when psychosis isn’t part of the picture.
For Mania and Maintenance
Several atypical antipsychotics are FDA-approved to treat manic or mixed episodes in bipolar disorder, and some are used for long-term maintenance as well.
Quetiapine (Seroquel) is one of the most versatile medications in this group. It’s FDA-approved for both acute manic episodes and bipolar depression, and is frequently used for maintenance. It also helps with anxiety and sleep disruption — two symptoms that commonly accompany mood episodes — which broadens its usefulness across different phases of the condition.
Aripiprazole (Abilify) is FDA-approved for manic and mixed episodes in bipolar I and for maintenance treatment. It has a different side effect profile from many other antipsychotics, with a lower likelihood of sedation or significant metabolic effects.
Olanzapine (Zyprexa) is FDA-approved for manic and mixed episodes, and for maintenance when combined with a mood stabilizer. It acts relatively quickly, which is useful during acute episodes. Weight gain and metabolic effects are more commonly associated with olanzapine than with some newer options — a trade-off prescribers discuss openly when considering it.
Specifically Approved for Bipolar Depression
Bipolar depression — the depressive phase — has historically been harder to treat than mania. Several atypical antipsychotics now carry FDA approval specifically for bipolar depression, which distinguishes them from medications used primarily for mania.
Lurasidone (Latuda) is approved for bipolar depression in adults and can be prescribed alone or alongside lithium or valproate. According to Psychiatric Times, it offers a meaningful balance of effectiveness and tolerability relative to other options in this class.
Lumateperone (Caplyta) is a newer medication approved for bipolar depression in adults. It can be used alone or with lithium or valproate. Its mechanism differs somewhat from other atypical antipsychotics — it acts across multiple receptor systems rather than primarily through dopamine blockade, which may account for differences in tolerability.
Olanzapine-fluoxetine combination (Symbyax) pairs an antipsychotic with an SSRI and was one of the first medications to receive FDA approval specifically for bipolar depression.
How Do Doctors Find the Right Medication for Bipolar Disorder?
There’s no blood test or imaging result that identifies the ideal medication for a given person. Bipolar treatment involves clinical judgment, detailed patient history, and realistically a degree of trial and error.
Psychiatrists weigh several factors when choosing a starting point: whether a person has bipolar I or bipolar II, whether they’re currently in a manic or depressive episode or somewhere in between, any prior medication responses (positive or negative), co-occurring physical or mental health conditions, and practical tolerability factors like sleep, weight, and energy levels.
Bipolar I and bipolar II aren’t identical conditions and don’t always respond the same way to the same medications. Bipolar I involves full manic episodes; bipolar II is characterized by hypomania, a less severe form of mania. This distinction shapes which medications have the strongest evidence base for a given person and which FDA approvals apply.
Most bipolar medications take weeks to reach their full effect, and what works well for one person may not work the same way for another. The goal is to find a regimen that stabilizes mood across both poles, the highs and the lows, with a side effect profile a person can realistically sustain long-term. Stopping medication without medical guidance significantly increases the risk of relapse, even during periods of stability.
When Bipolar Disorder and Substance Use Occur Together
Bipolar disorder and substance use disorder frequently co-occur. According to research published in peer-reviewed literature via NCBI, the lifetime prevalence of substance use disorders in people with bipolar I is at least 40% — one of the highest rates of any psychiatric condition. SAMHSA’s advisory on bipolar disorder and co-occurring substance use disorders identifies this population as particularly complex to treat precisely because both conditions affect mood, behavior, and how well medications work.
Substance use can destabilize mood, interfere with how bipolar medications work, and make it harder to distinguish between symptoms of the disorder and the effects of substances. A treatment approach that addresses only one condition tends to produce limited and short-lived results.
When both are present, the most effective approach is integrated treatment: care that simultaneously addresses bipolar disorder and substance use disorder rather than treating them as separate problems to be handled one at a time. This is sometimes called dual diagnosis or co-occurring disorder treatment.At Discover Recovery, treating co-occurring mental health conditions — including bipolar disorder — alongside substance use disorder is central to how we work. Learn more about our dual diagnosis treatment programs or reach out to our team at 866.719.2173.
Frequently Asked Questions About Bipolar Medications
What is the most commonly prescribed medication for bipolar disorder?
There’s no single answer — it depends on the type of bipolar disorder and the phase a person is in. Lithium has historically been the most studied first-line option, particularly for bipolar I with classic manic episodes. Quetiapine is also widely prescribed given its effectiveness across multiple phases of the condition. Most people with bipolar disorder take a combination of medications rather than relying on one drug alone.
How long does it take for bipolar medication to work?
It varies by medication and what it’s being used for. Lithium typically takes one to two weeks to show effects on acute mania; its full mood-stabilizing benefit builds over months. Lamotrigine is titrated slowly over several weeks before reaching a therapeutic dose. Atypical antipsychotics often work more quickly during acute episodes. Most maintenance medications are evaluated over a period of months before conclusions about their effectiveness are drawn.
Do bipolar medications cause weight gain?
Some do. Certain atypical antipsychotics — particularly olanzapine and quetiapine — and valproate are associated with weight gain and metabolic changes. Others, such as aripiprazole and lamotrigine, have a more favorable profile in this area. Prescribers weigh these effects against clinical benefit, and monitoring metabolic markers is standard practice during long-term treatment.
What happens if you stop taking bipolar medication?
Stopping bipolar medication without medical guidance significantly increases the risk of a mood episode returning — even for people who have been stable for a long time. That stability is often a direct result of the medication working. Any decision to reduce or discontinue medication should be made with a prescriber, not independently.
Does bipolar disorder require medication for life?
For most people with bipolar I, long-term maintenance medication is recommended to reduce the frequency and severity of episodes over time. The appropriate duration depends on the individual’s history, episode patterns, and response to medication. These are decisions made with a psychiatrist based on the full clinical picture, not general rules that apply to everyone equally.
Reviewed By: Dr. Kevin Fischer, M.D.
Kevin Fischer, MD is an experienced leader in the fields of Internal Medicine and Addiction Medicine. He works with patients suffering from Substance Use Disorder to evaluate their comprehensive health needs and prescribe Medication-Assisted Treatment (MAT). In addition, he mentors aspiring health professionals and leads collaborative care through team-based medical models. He also directs treatment strategies and streamlines clinical protocols for effective substance use recovery.